Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06526520

Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer

Status
Recruiting
Phase
Study type
Observational
Enrollment
5 (estimated)
Sponsor
ART Fertility Clinics LLC · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

To investigate the levels of Relaxin in different types of endometrial preparation for a frozen embryo transfer cycle. Up to now it is unclear, whether ovulation with a functional corpus luteum (CL) will be present in a natural proliferative phase (NPP) endometrial preparation approach.

Detailed description

The last years have seen a distinct shift from fresh (fresh ET) to frozen embryo transfer (FET) cycles. Furthermore it became obvious, that the endometrial preparation approach has a significant impact on the course of the pregnancy and that a HRT endometrial preparation approach is associated with a higher risk for bleeding and miscarriages in early pregnancy and for the development of pregnancy induced hypertension and pre-eclampsia later in pregnancy. These conditions are attributed to the absence of a CL in the HRT approach. Lately a new endometrial preparation approach is discussed and performed, the so called natural proliferative phase protocol, in which the follicle growth is monitored and when the lining is deemed to have a sufficient thickness and the triple lining pattern, exogeneous progesterone is started to induce secretory transformation before spontaneous ovulation. Despite some studies showing, that exogeneous progesterone administration might induce ovulation, it is not clear whether there will be a CL, producing Relaxin, in the NPP approach.

Conditions

Interventions

TypeNameDescription
DRUGExposure to progesterone or HRT medicationto add either progesterone only in the NPP protocol or E2 and progesterone in a HRT protocol

Timeline

Start date
2024-08-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2024-07-29
Last updated
2025-02-21

Locations

1 site across 1 country: United Arab Emirates

Source: ClinicalTrials.gov record NCT06526520. Inclusion in this directory is not an endorsement.